MapTrek to Increase Activity Among Patients at Risk for Type 2 Diabetes
| Status: | Completed |
|---|---|
| Conditions: | Obesity Weight Loss, Endocrine, Diabetes, Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 21 - 80 |
| Updated: | 10/18/2018 |
| Start Date: | May 15, 2017 |
| End Date: | May 4, 2018 |
MapTrek, an Interactive, m-Health Intervention to Increase Activity Among Patients at Risk for Type 2 Diabetes
The overarching objective of our work is to provide an inexpensive and scalable m-health tool
to increase both volume and intensity of physical activity and reduce sedentary behavior in
patients at risk for type 2 diabetes. The objective of this study is to pilot test MapTrek, a
text-messaging based intervention.
to increase both volume and intensity of physical activity and reduce sedentary behavior in
patients at risk for type 2 diabetes. The objective of this study is to pilot test MapTrek, a
text-messaging based intervention.
This study will randomize participants to 2 groups, an intervention group that will receive a
Fitbit and MapTrek, and a control group that will receive a Fitbit only. This study has 3
specific aims.
Aim 1- To determine if patients randomized to MapTrek walk more than the control patients.
Aim 2- To determine if patients randomized to MapTrek generally walk at a faster pace during
the day than control patients.
Aim 3- To determine if patients randomized to MapTrek have less sedentary time during the day
than the control patients.
We expect to collect sufficient data to demonstrate the effectiveness of MapTrek, our
prototype m-health tool, as an intervention to increase physical activity, heighten intensity
of activity, and reduce sedentary behavior among a cohort of patients at risk for type 2
diabetes.
Fitbit and MapTrek, and a control group that will receive a Fitbit only. This study has 3
specific aims.
Aim 1- To determine if patients randomized to MapTrek walk more than the control patients.
Aim 2- To determine if patients randomized to MapTrek generally walk at a faster pace during
the day than control patients.
Aim 3- To determine if patients randomized to MapTrek have less sedentary time during the day
than the control patients.
We expect to collect sufficient data to demonstrate the effectiveness of MapTrek, our
prototype m-health tool, as an intervention to increase physical activity, heighten intensity
of activity, and reduce sedentary behavior among a cohort of patients at risk for type 2
diabetes.
Inclusion Criteria:
- At least 21 years old
- English speaker
- Have a smart phone with texting and internet capabilities
- No aversion to research studies
- No active mental health conditions
- 1) Have a BMI > or equal to 25 and a history of hemoglobin A1C level between 5.7 and
6.4%, or 2) have a BMI > or equal to 30.
Exclusion Criteria:
- Pregnancy
- Prisoner status
- Taking insulin or other diabetic medications
We found this trial at
1
site
Coralville, Iowa 52241
Principal Investigator: Philip M Polgreen, MD
Phone: 319-678-8037
Click here to add this to my saved trials
